Clinical Trials Browser

Interventional × Uveal Melanoma × Thalidomide × Clear all

NCT00005815 2013-06-19

Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma

Phase 1/2 Completed

Uveal Melanoma, Melanoma

NCT00072345 2013-01-18

Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma

Phase 2 Completed

Uveal Melanoma, Melanoma